Adverse events associated with medical cannabis reported within a centralized call center
Abstract Introduction: The use of medical cannabis products is expanding, yet real-world data on associated adverse events (AEs) remain limited.…
Real-world evidence
Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis
Abstract Background: With the increasing use of medical cannabis (MC), there is growing evidence suggesting that MC may be an…
Association between cannabis use and ocular inflammatory disease: a large-scale cohort study
Abstract Objective: Cannabis use has increased substantially worldwide, yet its association with inflammatory eye diseases remains poorly understood. This study…
How to ESCAPE from Pain? An Observational Study on Improving Pain and Quality of Life with the Cannamedical® Hybrid Cannabis Extract
Abstract Introduction: Chronic pain remains a challenge, with standard therapies often providing inadequate pain relief and causing undesirable side effects.…
Controlled Inhalation of Tetrahydrocannabinol-Predominant Cannabis Flos Mitigates Severity of Post-Traumatic Stress Disorder Symptoms and Improves Quality of Sleep and General Mood in Cannabis-Experienced UK Civilians: A Real-World, Observational Study
Abstract Introduction: Approximately 4% of the UK population experiences PTSD. Individuals must exhibit symptoms across four clusters to receive a…
Associations of comorbid substance use disorders with clinical outcomes in schizophrenia using electronic health record data
Abstract Background and hypothesis: Schizophrenia and comorbid substance use disorders (SUDs) are associated with poor treatment outcomes but differences between…
Prediction of Adverse Events Risk in Patients with Comorbid Post- Traumatic Stress Disorder and Alcohol Use Disorder Using Electronic Medical Records by Deep Learning Models
Abstract Background: Prediction of high-risk events in mental disorder patients is crucial. In our previous study, we developed a deep…